ATRA Atara Biotherapeutics Stock Forecast Period (n+7) 22 Dec 2020


Stock Forecast


As of Tue Dec 22 2020 00:00:01 GMT+0000 (Coordinated Universal Time) shares of ATRA Atara Biotherapeutics 3.93 percentage change in price since the previous day's close. Around 1427826 of 82816000 changed hand on the market. The Stock opened at 21.22 with high and low of 21.06 and 22.81 respectively. The price/earnings ratio is: - and earning per share is -4.62. The stock quoted a 52 week high and low of 4.52 and 28.2 respectively.

BOSTON (AI Forecast Terminal) Tue, Dec 22, '20 AI Forecast today took the forecast actions: In the context of stock price realization of ATRA Atara Biotherapeutics is a decision making process between multiple investors each of which controls a subset of design variables and seeks to minimize its cost function subject to future forecast constraints. That is, investors act like players in a game; they cooperate to achieve a set of overall goals.Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network and Support Vector Machines. Machine Learning based technical analysis (n+7) for ATRA Atara Biotherapeutics as below:
Using machine learning modified The random walk index model RWI equivalent to a model of stock market dynamics with price expectations, we analyze the reaction of investors to speculations. Analyzing those data we were able to establish the amount by which each stock felt the speculative attacks, a dampening factor which expresses the capacity of a market of absorving a shock, and also a frequency related with volatility after the speculation. Using the correlation matrices, the speculative buffer for the shares of ATRA Atara Biotherapeutics as below:

ATRA Atara Biotherapeutics Credit Rating Overview


We rerate ATRA Atara Biotherapeutics because of no indications exist that private equity, management, or shareholders may reduce or prevent the maintenance of capital. We use econometric methods for period (n+7) simulate with Simple Moving Average (SMA) Wilcoxon Rank-Sum Test. Reference code is: 3266. Beta DRL value REG 19 Rational Demand Factor LD 5113.747799999999. Asset divestitures. We do not include asset sales as a source of liquidity unless they are contracted and proceeds will be received in the time period being measured under the liquidity descriptor (even when the disposed assets are reported under discontinued operations in a company's financial statements). Credit Rating AI Process rely on primary sources of information: Sec Filings, Financial Statements, Credit Ratings, Semantic Signals. Take a look at Machine Learning section for Financial Deep Reinforcement Learning.

Oscillators are used for generating credit risk signals by using the semantic and financial signals. The value of the oscillators indicate the strength of trend. Using the correlation matrices, the risk map for ATRA Atara Biotherapeutics as below:
Frequently Asked QuestionsQ: What is ATRA Atara Biotherapeutics stock symbol?
A: ATRA Atara Biotherapeutics stock referred as NASDAQ:ATRA
Q: What is ATRA Atara Biotherapeutics stock price?
A: On share of ATRA Atara Biotherapeutics stock can currently be purchased for approximately 22.5
Q: Do analysts recommend investors buy shares of ATRA Atara Biotherapeutics ?
A: Machine Learning utilizes multiple learning algorithms to obtain better predictive powers. In our research, we utilize machine learning to combine the results from the Neural Network and Support Vector Machines. View Machine Learning based technical analysis for ATRA Atara Biotherapeutics at daily forecast section
Q: What is the earning per share of ATRA Atara Biotherapeutics ?
A: The earning per share of ATRA Atara Biotherapeutics is -4.62
Q: What is the market capitalization of ATRA Atara Biotherapeutics ?
A: The market capitalization of ATRA Atara Biotherapeutics is 1863360000
We work across the world

From London to San Francisco, to our home base in (Saint Helier) Jersey, we’re looking for extraordinary and creative scientists to help us drive the field forward.

Disclaimers: AC Investment Inc. currently does not act as an equities executing broker or route orders containing equities securities. All data and information is provided “as is” for personal informational purposes only, and is not intended for trading purposes or advice. Please consult your broker or financial representative to verify pricing before executing any trade.

77 Massachusetts Avenue Cambridge, MA 02139 617-253-1000 pr@ademcetinkaya.com